Literature DB >> 32712519

Autophagy-related MicroRNAs in chronic lung diseases and lung cancer.

Samaneh Rezaei1, Maryam Mahjoubin-Tehran1, Seyed Hamid Aghaee-Bakhtiari2, Amin Jalili1, Ahmad Movahedpour3, Haroon Khan4, Mohsen Moghoofei5, Zahra Shojaei6, Michael R Hamblin7, Hamed Mirzaei8.   

Abstract

Chronic lung disease has become a leading cause of death in recent years. Despite several attempts to discover and develop new therapeutic approaches, patients often suffer a poor quality of life, and are faced with an increased risk of developing lung cancer. Lung cancer often occurs as an end-stage after years of chronic lung disease. An increased understanding of the pathophysiology of chronic lung disease may be obtained from studying the role of autophagy in its initiation and progression. MicroRNAs (miRNAs) play a critical role in the modulation of autophagy, and their deregulation could be associated with the initiation and progression of several chronic lung diseases. Herein, we documented that up/down regulation of miRNAs can activate or inhibit autophagy in chronic lung diseases including lung cancer. Therefore, theses miRNAs could be a promising therapeutic tool for lung cancer specially in drug-resistance lung cancer cells.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Chronic obstructive lung disease; Cystic fibrosis; Idiopathic pulmonary fibrosis; Lung cancer; microRNAs

Mesh:

Substances:

Year:  2020        PMID: 32712519     DOI: 10.1016/j.critrevonc.2020.103063

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

Review 1.  Non-coding RNAs associated with autophagy and their regulatory role in cancer therapeutics.

Authors:  Surbhi Kumari Barnwal; Hrushikesh Bendale; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-05-10       Impact factor: 2.742

2.  Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma.

Authors:  Eun-Jin Yun; Sangwoo Kim; Jer-Tsong Hsieh; Seung Tae Baek
Journal:  Cell Death Dis       Date:  2020-09-17       Impact factor: 8.469

Review 3.  The Regulating Effect of Autophagy-Related MiRNAs in Kidney, Bladder, and Prostate Cancer.

Authors:  Kai Huang; Xiaoxin Sun; Haotian Wu; Jun Zhao; Yuli Jian; Zhongyang Xu; Shujing Wang; Deyong Yang
Journal:  J Oncol       Date:  2021-04-22       Impact factor: 4.375

Review 4.  Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions.

Authors:  Leila Erfanparast; Mohammad Taghizadieh; Ali Akbar Shekarchi
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

Review 5.  Autophagy: A Key Regulator of Homeostasis and Disease: An Overview of Molecular Mechanisms and Modulators.

Authors:  Laura Gómez-Virgilio; Maria-Del-Carmen Silva-Lucero; Diego-Salvador Flores-Morelos; Jazmin Gallardo-Nieto; Gustavo Lopez-Toledo; Arminda-Mercedes Abarca-Fernandez; Ana-Elvira Zacapala-Gómez; José Luna-Muñoz; Francisco Montiel-Sosa; Luis O Soto-Rojas; Mar Pacheco-Herrero; Maria-Del-Carmen Cardenas-Aguayo
Journal:  Cells       Date:  2022-07-22       Impact factor: 7.666

6.  Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer.

Authors:  Mei Ruan; Liyan Sun; Wen Qiu; Yanjie Dong; Chunmei Fang; Haiyan Cui; Jiansheng Rong
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

7.  C1QTNF6 regulated by miR-29a-3p promotes proliferation and migration in stage I lung adenocarcinoma.

Authors:  Guofu Lin; Lanlan Lin; Hai Lin; Yingxuan Xu; Wenhan Chen; Yifei Liu; Jingyang Wu; Shaohua Chen; Qinhui Lin; Yiming Zeng; Yuan Xu
Journal:  BMC Pulm Med       Date:  2022-07-25       Impact factor: 3.320

8.  Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA.

Authors:  Thorben Fischer; Inga Winter; Robert Drumm; Marc Schneider
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.